James McCullough
Net worth: 99 660 $ as of 31/05/2026
Net worth: 99 660 $ as of 31/05/2026
James Renwick McCullough is the founder of Renalytix Plc, founded in 2018, where the title held is Chief Executive Officer & Director.
Mr. McCullough is also the founder of Paige.
AI, Inc...
Current jobs include Chairman at BalletNext, Inc., Director at The Bonnie J.
Addario Lung Cancer Foundation, Director at Kantaro Biosciences LLC, Director at Renalytix AI, Inc., and Director at Go2 Foundation For Lung Cancer.
Former jobs include Chief Executive Officer at Exosome Diagnostics, Inc. from 2008 to 2014, Director at Quentra Networks, Inc., Director at Ausam Biotechnologies, Inc., Director at TAVEC Pharmaceuticals, Non-Executive Director at Verici Dx Plc from 2020 to 2026, Independent Non-Executive Director at LungLife AI, Inc. from 2019 to 2024, and Managing Partner at Renwick Capital LLC from 2014 to 2021.
Education includes undergraduate studies at Boston University and an MBA from Columbia Business School.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RENALYTIX PLC 0.78% | 12/02/2026 | 3,430,096 ( 0.78% ) | 83 214 $ | 31/05/2026 |
VERICI DX PLC 0.19% | 31/12/2024 | 2,870,110 ( 0.19% ) | 16 446 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| RENALYTIX PLC | Founder | 15/03/2018 |
BalletNext, Inc.
BalletNext, Inc. Internet Software/ServicesTechnology Services Operates as a crossing platform creating collaborations between artists, students and institutions | Chairman | - |
The Bonnie J. Addario Lung Cancer Foundation
The Bonnie J. Addario Lung Cancer Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a philanthropy devoted to eradication Lung Cancer | Director/Board Member | - |
Kantaro Biosciences LLC
Kantaro Biosciences LLC Medical SpecialtiesHealth Technology Develops diagnostic test kits | Director/Board Member | - |
Renalytix AI, Inc. | Director/Board Member | - |
Go2 Foundation For Lung Cancer
Go2 Foundation For Lung Cancer Go2 Foundation For Lung Cancer is a national nonprofit organization focused on confronting lung cancer through education, support, advocacy, and research. The private company is based in Washington, DC. The foundation provides resources on lung cancer types, risk factors, symptoms, diagnosis, staging, and treatment options such as surgery, chemotherapy, radiation, targeted therapy, immunotherapy, biomarker testing, and clinical trials. It promotes early detection through lung cancer screening with low-dose CT scans and supports a national network of centers of excellence for lung cancer care. The organization offers personalized assistance via a free helpline, peer support programs, online social groups, coping skills workshops, and educational events. Go2 Foundation advances lung cancer research through initiatives like the lung cancer registry and partnerships with research institutes, and advocates for increased research funding, improved healthcare access, and reduced stigma. Community engagement is encouraged through fundraising, advocacy campaigns, awareness events, and sharing personal stories. Educational materials are provided in multiple formats and languages. The CEO of the company is Laurie Fenton Ambrose. | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| VERICI DX PLC | Director/Board Member | 31/03/2026 |
| LUNGLIFE AI, INC. | Director/Board Member | 24/10/2024 |
Renwick Capital LLC
Renwick Capital LLC Investment ManagersFinance Provides investment services | Corporate Officer/Principal | 01/01/2021 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 16 |
|---|---|
Quentra Networks, Inc.
Quentra Networks, Inc. Specialty TelecommunicationsCommunications Sells wholesale long distance services | Communications |
LungLife AI, Inc.
LungLife AI, Inc. Medical SpecialtiesHealth Technology Develops early detection solutions for lung cancer | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ausam Biotechnologies, Inc.
Ausam Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biophysics and physiology research and development services | Commercial Services |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a biofluid-based diagnostic center | Health Services |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Bonnie J. Addario Lung Cancer Foundation
The Bonnie J. Addario Lung Cancer Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a philanthropy devoted to eradication Lung Cancer | Commercial Services |
Paige.Ai, Inc.
Paige.Ai, Inc. Packaged SoftwareTechnology Services Operates as an AI company specializing in digital pathology | Technology Services |
Renalytix Plc
Renalytix Plc Packaged SoftwareTechnology Services Provides artificial intelligence for kidney disease | Technology Services |
TAVEC Pharmaceuticals
TAVEC Pharmaceuticals Pharmaceuticals: MajorHealth Technology Develops novel drugs pharm | Health Technology |
Renwick Capital LLC
Renwick Capital LLC Investment ManagersFinance Provides investment services | Finance |
BalletNext, Inc.
BalletNext, Inc. Internet Software/ServicesTechnology Services Operates as a crossing platform creating collaborations between artists, students and institutions | Technology Services |
Kantaro Biosciences LLC
Kantaro Biosciences LLC Medical SpecialtiesHealth Technology Develops diagnostic test kits | Health Technology |
Renalytix AI, Inc. | Health Services |
Verici Dx Plc
Verici Dx Plc Medical/Nursing ServicesHealth Services Provides kidney transplantation services | Health Services |
Go2 Foundation For Lung Cancer
Go2 Foundation For Lung Cancer Go2 Foundation For Lung Cancer is a national nonprofit organization focused on confronting lung cancer through education, support, advocacy, and research. The private company is based in Washington, DC. The foundation provides resources on lung cancer types, risk factors, symptoms, diagnosis, staging, and treatment options such as surgery, chemotherapy, radiation, targeted therapy, immunotherapy, biomarker testing, and clinical trials. It promotes early detection through lung cancer screening with low-dose CT scans and supports a national network of centers of excellence for lung cancer care. The organization offers personalized assistance via a free helpline, peer support programs, online social groups, coping skills workshops, and educational events. Go2 Foundation advances lung cancer research through initiatives like the lung cancer registry and partnerships with research institutes, and advocates for increased research funding, improved healthcare access, and reduced stigma. Community engagement is encouraged through fundraising, advocacy campaigns, awareness events, and sharing personal stories. Educational materials are provided in multiple formats and languages. The CEO of the company is Laurie Fenton Ambrose. |
Select your edition
All financial news and data tailored to specific country editions